Código QR

Design and development of novel, short, stable dynorphin-based opioid agonists for safer analgesic therapy

Kappa opioid receptors have exceptional potential as an analgesic target, seemingly devoid of many problematic Mu receptor side-effects. Kappa-selective, small molecule pharmaceutical agents have been developed, but centrally mediated side-effects limit clinical translation. We modify endogenous dyn...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Rink-Jan Lohman, Karnaker Reddy Tupally, Ajit Kandale, Peter J. Cabot, Harendra S. Parekh
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2023-03-01
Colecção:Frontiers in Pharmacology
Assuntos:
Acesso em linha:https://www.frontiersin.org/articles/10.3389/fphar.2023.1150313/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!